JCVI says YES to LAIV for preventing flu in children

United Kingdom
NITAGs
30 August 2016

In August 2016, JCVI was asked to review updated data from the 2015/16 season in the UK and other countries, in light of emerging evidence of low effectiveness of the nasal spray vaccine, lower than inactivated vaccine, reported in the United States (US). After reviewing evidence from across the UK, Finland, Canada and the United States following the 2015/16 influenza season, much of which demonstrates good overall effectiveness, JCVI continues to recommend using the live attenuated influenza vaccine (LAIV, the nasal spray vaccine) for preventing flu in children and strongly supports the continuation of the UK childhood influenza immunisation programme. 

téléchargement.png
Documents to download

Related News & Events

  • NITAGs

    Third Global NITAG Network (GNN) meeting

    16.01.2019

    The Global NITAG Network (GNN) meeting was organized this year by the Public Health Agency of Canada with the strong support of WHO HQ. This annual meeting brought National Immunization Technical Advisory Group (NITAG) members from across the globe to Ottawa to discuss the network’s activities, the barriers to reach the GVAP target and the lessons learnt in building NITAG structure and evaluating NITAGs.

    Read more
  • 15 -17
    January
    Congo
    NITAGs

    AFRO RITAG Meeting

    WHO AFRO
    WHO regional office for Africa
  • Sweden
    NITAGs

    Changing national vaccination programmes in Sweden

    19.12.2018

    This report outlines how the Public Health Agency of Sweden organizes and investigates changes to national vaccination programmes. The main target group of the English version of the report is National Immunization Technical Advisory Groups (NITAGs) and their Secretariats in other countries.

    Read more